Cargando…
Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
Severe coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is characterized by an unpredictable disease course, with variable presentations of different organ systems. The clinical manifestations of COVID-19 are highly variable ranging from...
Autores principales: | Ghaebi, Mahnaz, Tahmasebi, Safa, Jozghorbani, Maryam, Sadeghi, Alireza, Thangavelu, Lakshmi, Zekiy, Angelina Olegovna, Esmaeilzadeh, Abdolreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046708/ https://www.ncbi.nlm.nih.gov/pubmed/33865882 http://dx.doi.org/10.1016/j.lfs.2021.119503 |
Ejemplares similares
-
Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches
por: Gowhari Shabgah, Arezoo, et al.
Publicado: (2021) -
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
por: Hadiloo, Kaveh, et al.
Publicado: (2023) -
Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells
por: Elahi, Reza, et al.
Publicado: (2018) -
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
por: Markov, Alexander, et al.
Publicado: (2021) -
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects
por: Rahbaran, Mohaddeseh, et al.
Publicado: (2022)